The Role of Serum Magnesium Levels in the Prevention and Management of Cardiac Arrhythmias
Abstract
Background and Purpose: Hypomagnesemia has been strongly implicated in the pathogenesis of cardiac arrhythmias due to its role in myocardial excitability and membrane stabilization. Serum magnesium acts as a natural calcium antagonist, and its deficiency promotes afterdepolarizations and increased automaticity in cardiac myocytes, predisposing to both atrial and ventricular arrhythmias. This abstract aims to summarize current evidence regarding the preventive and therapeutic significance of optimal magnesium levels in arrhythmia management.
Methods: A synthesis of cross-sectional, cohort, and interventional studies published between 2008 and 2024 was performed. Data from community-based studies, including the Atherosclerosis Risk in Communities (ARIC) and the Chronic Renal Insufficiency Cohort (CRIC), were analyzed alongside randomized clinical trials evaluating magnesium supplementation in coronary artery bypass surgery and heart failure patients.
Results: Low serum magnesium levels (<0.75 mmol/L) were consistently associated with a higher risk of atrial fibrillation and premature ventricular contractions. Magnesium repletion reduced proarrhythmic risk in conditions such as acute myocardial infarction, heart failure, and postoperative cardiac surgery, though findings varied depending on baseline magnesium status and duration of supplementation. Meta-analyses indicated that maintaining magnesium within the mid-normal range was associated with reduced incidence of sudden…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
- A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
- Bioaccessibility and bioavailability of phenolic compounds
- The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
- Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.